Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVT-301 in Parkinson's Disease "Off" Episodes
NCT01617135Phase 2Completed
- Sponsor
- Acorda Therapeutics
- Start
- May 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of levodopa in Parkinson's disease (PD), sponsored by Acorda Therapeutics. Started May 2012; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01617135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01617135.